Proposal for a national coverage determination for the treatment of varicose veins and venous disease due to disparate Centers for Medicare and Medicaid Services local coverage determination policies

The clinical relevance of anterior accessory great saphenous vein reflux

“…[8][9][10] Despite these facts, abundant controversy remains as those who present with AAGSV reflux as the initial presenting pattern represent the square peg that no longer fits under existing coverage policy restrictions. 11,12 Major insurance carriers including Aetna, Anthem, Cigna, Humana, and UnitedHealthcare as well as multiple smaller regional carriers continue to restrict treatment of the AAGSV despite evidence supporting its severity in patients with symptomatic venous incompetence (Table I). Population registries offer the ability to study a disease state over a wide spectrum of providers and geography.…”